DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma

Anal Carcinoma, Version 2.2012

(2017) Al B. Benson et al.   Journal of the National Comprehensive Cancer Network

Signature patterns of human papillomavirus type 16 in invasive anal carcinoma

(2012) Séverine Valmary-Degano et al.   HUMAN PATHOLOGY

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

(2012) Leonard L. Gunderson et al.   JOURNAL OF CLINICAL ONCOLOGY

Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial

(2012) Didier Peiffert et al.   JOURNAL OF CLINICAL ONCOLOGY

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

(2011) Jochen H Lorch et al.   LANCET ONCOLOGY

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) R. Glynne-Jones et al.   ANNALS OF ONCOLOGY

Prognostic Significance of p16INK4Aand Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial

(2010) Danny Rischin et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck

(2009) Pernille Lassen et al.   JOURNAL OF CLINICAL ONCOLOGY

Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status

(2009) Nadine Lukan et al.   ONCOLOGY

Activity of paclitaxel in metastatic squamous anal carcinoma

(2008) Thierry Alcindor   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer

(2008) Bhavna Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY